USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'explosive proof equipment'
- Did you mean
- explosive pfoo equipment
- explosive pfof equipment
- Related search terms
- equipment manufacturing
- equipment manufacturer for battery
- explosive vertic device market
- explosive vending device market
- explosive provid equipment
-
20 Nov 2017 | North America | Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
25 Jun 2026 | Global | Technology Research
Quantum Sensors Transitioning from Lab to Industry: Ultra-Precision Measurement for Healthcare, Defense, and Manufacturing
Translating Quantum Innovation into Industry-Ready Measurement Systems
Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environments toward scalable, field-ready systems that meet ...
$4,950.00 -
17 Mar 2026 | Global | Market Research
Growth Opportunities in Global Pharmaceutical Industry, 2026
Platforms, Policies, and Pathways: Convert Complexity into Growth
The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...
$4,950.00
